Tandem Diabetes Care (NASDAQ:TNDM) Coverage Initiated by Analysts at Canaccord Genuity Group
Canaccord Genuity Group began coverage on shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) in a research note issued to investors on Thursday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $57.00 price target on the medical device company’s stock. Several other brokerages have also commented on TNDM. Leerink Partnrs upgraded […]
More Stories
Order of the Sinking Star is Ready to Launch on PlayStation 5 and TV
The creator of Braid and The Witness, Jonathan Blow, is returning with an all-new puzzle video game, Order of the...
Netflix’s Upcoming Drama, All the Truth in My Lies: Release Date, Cast, and More
Excited to know about the upcoming Spanish drama on Netflix, All the Truth in My Lies. If you love watching...
Obsession (2026): Release Date, Cast Members, Trailer, Plot, and More
Be Alert: Spoilers Ahead! Are you also a lover of horror shows and looking for upcoming horror movies and series...
Desire 2026: Release Date, Cast Members, Trailer, Audio, and More
Netflix is expanding its international movie lineup with intense action, thriller, and drama that explore the complexities of human emotions....
AI Assistants Overwhelmingly Cite Third-Party Lists, Not Company Homepages, Study Finds
Artificial intelligence assistants overwhelmingly cite third-party “best-of” and comparison pages rather than companies’ own websites, according to a new study...
How Businesses are Incorporating AI Video Into Sales Processes
Over the last few years, businesses have had to rethink their traditional sales processes. Consumers are more empowered to complete...